A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...

The firm will use the proceeds to advance BE-101 for hemophilia B through clinical proof-of-concept testing and BE-102 for hypophosphatasia into the clinic.

Medically reviewed by Doru Paul, MD T-cell lymphoma is a type of lymphatic cancer that starts in the T lymphocytes (T cells), ...

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...

Fighting off infections when one has a chronic disease is a common problem, and during the COVID-19 pandemic that scenario ...

The authors' work 3, however, primarily highlights the role of memory B-cell IL-10 in downregulating the active inflammatory response in EAE (that is, disease remission), less so the role of B ...

Professor Markus Sauer from the Biocentre of Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany ...